Apoptotic sphingolipid ceramide in cancer therapy.

Apoptotic sphingolipid ceramide in cancer therapy.
复制标题

DOI:
10.1155/2011/565316
复制
发表时间:
2011
期刊:
影响因子:
5.3
通讯作者:
Lin CF
Lin CF
中科院分区:
其他
文献类型:
--
作者:
Huang WC;Chen CL;Lin YS;Lin CF

文献摘要

参考文献

被引文献

相似文献

细胞凋亡,也称为程序性细胞死亡,在生理和病理上参与细胞内稳态。凋亡信号的逃逸是癌症肿瘤发生中常用的关键策略。神经酰胺是鞘脂分解产物的衍生物,作为多种细胞外刺激的第二信使,包括生长因子、化学试剂和环境应激,如缺氧、热应激以及辐射。此外,神经酰胺作为肿瘤抑制脂质,因为各种应激刺激通过增加细胞内神经酰胺引发凋亡信号而引起凋亡。神经酰胺生成和鞘脂代谢的缺陷导致癌细胞存活和癌症治疗抗性。或者,靶向神经酰胺代谢以纠正这些缺陷可能提供克服癌症治疗抗性的机会。
Apoptosis, also called programmed cell death, is physiologically and pathologically involved in cellular homeostasis. Escape of apoptotic signaling is a critical strategy commonly used for cancer tumorigenesis. Ceramide, a derivative of sphingolipid breakdown products, acts as second messenger for multiple extracellular stimuli including growth factors, chemical agents, and environmental stresses, such as hypoxia, and heat stress as well as irradiation. Also, ceramide acts as tumor-suppressor lipid because a variety of stress stimuli cause apoptosis by increasing intracellular ceramide to initiate apoptotic signaling. Defects on ceramide generation and sphingolipid metabolism are developed for cancer cell survival and cancer therapy resistance. Alternatively, targeting ceramide metabolism to correct these defects might provide opportunities to overcome cancer therapy resistance.
DOI: 10.1016/j.ccr.2006.03.005
发表时间: 2006-04-01
期刊: CANCER CELL
影响因子: 50.3
作者:
Carracedo, A;Lorente, M;Velasco, G
通讯作者: Velasco, G
DOI: 10.1002/jnr.20471
发表时间: 2005-05-15
影响因子: 4.2
作者:
Dahmer, MK
通讯作者: Dahmer, MK
DOI: 10.1007/s00109-009-0514-8
发表时间: 2009-11-01
影响因子: 4.7
作者:
Dumitru, Claudia A.;Sandalcioglu, Ibrahim E.;Gulbins, Erich
通讯作者: Gulbins, Erich
DOI: 10.1016/j.bbrc.2006.02.070
发表时间: 2006-04-21
影响因子: 3.1
作者:
Akao, Y;Banno, Y;Nozawa, Y
通讯作者: Nozawa, Y
DOI: 10.1038/leu.2008.95
发表时间: 2008-05-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Bonhoure, E.;Lauret, A.;Cuvillier, O.
通讯作者: Cuvillier, O.